ClassID:

97124

C07K16/121 - CPC Classification

Classification description:

Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)

Recent Application in this class:
#1
20250360193
2025-11-27

VACCINE AGAINST CAMPYLOBACTER JEJUNI

#2
20250270298
2025-08-28

MULTIVALENT ANTI-CAMPYLOBACTER ANTIBODIES AND VACCINE

#3
20240002481
2024-01-04

EXPRESSION AND MANUFACTURING OF PROTEIN THERAPEUTICS IN SPIRULINA

#4
20220404367
2022-12-22

NOVEL ANTIBODIES FOR DETECTING GASTRIC CANCER

#5
20220193216
2022-06-23

Helicobacter therapeutic

#6
20210299186
2021-09-30

VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER

#7
20210292375
2021-09-23

METHOD FOR DIAGNOSING INFECTION WITH HELICOBACTER SUIS

#8
20210284718
2021-09-16

Antibodies against species

#9
20210179694
2021-06-17

Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM

#10
20200317756
2020-10-08

Antibodies and test devices for the detection of bacteria of the genus

#11
20200299360
2020-09-24

COMPOSITIONS AND METHODS FOR TREATMENT IN BROAD-SPECTRUM, UNDIFFERENTIATED OR MIXED CLINICAL APPLICATIONS

#12
20200271650
2020-08-27

ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI

#13
20200108135
2020-04-09

HELICOBACTER THERAPEUTIC

#14
20200010534
2020-01-09

Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody

#15
20190178890
2019-06-13

Antibody to cytolethal distending toxin of Campylobacter jejuni

#16
20190167779
2019-06-06

Synthetic antigen constructs against campylobacter jejuni

#17
20180353581
2018-12-13

Vaccination with MICA/B alpha 3 domain for the treatment of cancer

#18
20180319871
2018-11-08

IgG, IgA and IgM antibody preparations, method of making and method of use in treatment

#19
20180142000
2018-05-24

Anti-campylobacter jejuni antibodies and uses therefor

#20
20170342138
2017-11-30

Method for and use of blocking immunosuppressive functions of pathogens

#21
20170342137
2017-11-30

Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody

#22
20170327564
2017-11-16

Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications

#23
20170165347
2017-06-15

HELICOBACTER THERAPEUTIC

#24
20170129941
2017-05-11

H. Pylori Lipopolysaccharide Outer Core Epitope

#25
20170082621
2017-03-23

Methods for diagnosing and treating infection

#26
20170058020
2017-03-02

Antibody preparations

#27
20160195528
2016-07-07

Method for the detection of H. pylori infection

#28
20150307597
2015-10-29

Anti-campylobacter jejuni antibodies and uses therefor

#29
20150306201
2015-10-29

Method for treating infections

#30
20150284674
2015-10-08

CAMPYLOBACTER BACTERIA AND DETECTION

#31
20150284449
2015-10-08

lipopolysaccharide outer core epitope

#32
20150184230
2015-07-02

Detection of bacteria belonging to the genus by targeting cytolethal distending toxin

#33
20150064170
2015-03-05

Antibody preparations

#34
20140170150
2014-06-19

N-linked glycan compounds

#35
20130295099
2013-11-07

N-linked glycan compounds

#36
20130115304
2013-05-09

Compositions and methods for modulating immune response

#37
20130052208
2013-02-28

Process for preparing an immunoglobulin composition

#38
20130045199
2013-02-21

Antibody preparations

#39
20130034556
2013-02-07

FREE HEXASACCHARIDE ISOLATED FROM SEVERAL CAMPYLOBACTER SPECIES

#40
20120301480
2012-11-29

lipopolysaccharide outer core epitope

#41
20120294850
2012-11-22

Ganglioside epitopes for treating Guillain-Barre syndrome

#42
20120164145
2012-06-28

lipopolysaccharide outer core epitope

#43
20120141458
2012-06-07

Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications

#44
20120034238
2012-02-09

Compositions and methods for treating hepatitis virus infection

#45
20120009198
2012-01-12

Compositions and Methods for Modulating Immune Response

#46
20110305704
2011-12-15

Antibody to cytolethal distending toxin of

#47
20110131669
2011-06-02

Ganglioside epitopes for treating guillain-barre syndrome

#48
20100273161
2010-10-28

Detection of bacteria belonging to the genus by targeting cytolethal distending toxin

#49
20100034846
2010-02-11

Method for treating infections

#50
20090208972
2009-08-20

CYTOTOXIC PROTEIN AND UTLIZATION THEREOF

#51
20090186075
2009-07-23

Composition

#52
20090074798
2009-03-19

System and method for the production of recombinant glycosylated proteins in a prokaryotic host

#53
20080233556
2008-09-25

CYTOTONIC PROTEIN AND UTLIZATION THEREOF

#54
20080213224
2008-09-04

Immunoglobulin against

#55
20080131453
2008-06-05

Campylobacter Jejuni Outer Membrane Protein Immunogenic Composition

#56
20070104731
2007-05-10

Helicobacter proteins and vaccines

#57
20070009975
2007-01-11

Method for detecting acid-resistant microorganisms in the stool

#58
20060210575
2006-09-21

Cytotoxic protein and utilization thereof

#59
20060193866
2006-08-31

H pylori antigens

#60
20050287628
2005-12-29

System and method for the production of recombinant glycosylated proteins in a prokaryotic host

#61
20050220894
2005-10-06

Colostrum-based composition

#62
20050176077
2005-08-11

Methods of inhibiting

#63
20050118197
2005-06-02

Polysaccharides of

#64
20050106159
2005-05-19

Campylobacter jejuni outer membrane protein immunogenic composition

#65
20050009108
2005-01-13

antigens in blood

#66
20050009037
2005-01-13

Helicobacter bizzozeronii outer membrane protein encoding gene and its use in diagnostic and treatment methods